Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120559
Published online Sep 15, 2026. doi: 10.4251/wjgo.120559
Published online Sep 15, 2026. doi: 10.4251/wjgo.120559
Figure 5 Compare the performance of 18F-fluorodeoxyglucose and 18F-fibroblast activation protein inhibitor-04 positron emission tomography in detecting primary tumors, lymph nodes, bone and peritoneal metastases, local recurrences.
Data are presented descriptively without statistical hypothesis testing. No P values are shown. LNM: Lymph node metastases; Mets: Metastases; Recs: Recurrences; PET/CT: Positron emission tomography/computed tomography; 18F-FAPI: 18F-fibroblast activation protein inhibitor; 18F-FDG: 18F-fluorodeoxyglucose.
- Citation: Xue XQ, Li QB, Fu HT, Hou L, Wang R, Shi X, Yu CJ. Comparative study of 18F-FAPI-04 and 18F-FDG PET/CT in the initial staging and postoperative metastasis detection of gastric cancer. World J Gastrointest Oncol 2026; 18(9): 120559
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/120559.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120559